Nutrien Review Following Investor Day
<p>RBC Capital analysts provided a review on <a href='https://financialmodelingprep.com/financial-summary/NTR'>Nutrien Ltd. (NYSE: NTR)</a> following the company’s investor update day, which helped highlight a realistic and achievable long-term outlook for the company and the ag/fertilizer sector. </p>
<p>The company highlighted a potential mid-cycle scenario at approximately 9 billion EBITDA, based on the planned new capacity additions in potash and nitrogen, and the company's view on structurally higher mid-cycle prices. This compares to approximately 5 billion EBITDA average from 2010 to 2021. The analysts believe this view is realistic given structural market changes that support higher normalized prices and the planned capacity additions.</p>
<p>The company also announced plans to raise potash production capability to 18Mt by 2025, up from 15Mt in 2022, at a cost of $150-200/ton.</p>

NYSE:, NTR